J Korean Med Sci.  2023 May;38(21):e166. 10.3346/jkms.2023.38.e166.

The Beginning of the Era of Digital Therapeutics in Korea: Challenges and Opportunities

Affiliations
  • 1Department of Psychiatry, Korea University College of Medicine, Seoul, Korea
  • 2Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea


Reference

1. Ministry of Food and Drug Safety. [Press Release] Digital therapeutics (DTx) bring about wider treatment options and improved convenience. Updated 2023. Accessed February 22, 2023. https://www.mfds.go.kr/eng/brd/m_61/view.do?seq=142&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1 .
2. Sim I. Mobile devices and health. N Engl J Med. 2019; 381(10):956–968. PMID: 31483966.
3. Sauermann S, Herzberg J, Burkert S, Habetha S. DiGA – A chance for the German healthcare system. J Eur CME. 2021; 11(1):2014047. PMID: 34992948.
4. Choi HJ, Dong JY, Kim EM, Jang JH. Digital therapeutics reimbursement system in Germany and its implications. HIRA Res. 2022; 2(1):24–35.
5. Ju JH, Sim B, Lee J, Lee JY. Reimbursement of digital therapeutics: future perspectives in Korea. Korean Circ J. 2022; 52(4):265–279. PMID: 35388995.
6. Stern AD, Brönneke J, Debatin JF, Hagen J, Matthies H, Patel S, et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit Health. 2022; 4(3):e200–e206. PMID: 35216754.
7. Cho CH, Lee HJ. Could digital therapeutics be a game changer in psychiatry? Psychiatry Investig. 2019; 16(2):97–98.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr